TAF1A RNA Polymerase I, TATA Box Binding Protein (TBP)-Associated Factor

A core component of the RNA polymerase I transcription initiation complex, essential for ribosomal RNA synthesis.

Gene Information Card

Symbol TAF1A
Full Name TATA-box binding protein associated factor, RNA polymerase I subunit A
Gene Type protein-coding
Chromosomal Location 1q42.13
NCBI Gene ID 9015 ncbi.nlm.nih.gov/gene/9015
Ensembl ID ENSG00000143178
UniProt ID Q15573
OMIM ID 604783
HGNC ID 11533
Aliases TAFI-110, TAFI110, TAF1A, SL1, TAFI110, TAFI-110

Description

TAF1A encodes a component of the transcription factor SL1 (selectivity factor 1) complex, which is required for RNA polymerase I-mediated transcription of ribosomal RNA genes. The protein directly interacts with the TATA box-binding protein (TBP) and other SL1 subunits to nucleate pre-initiation complex formation at the ribosomal DNA promoter. TAF1A is essential for ribosome biogenesis and cell growth.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Colorectal cancer Overexpression of TAF1A may drive rRNA synthesis and cell proliferation; altered expression linked to tumorigenesis. COSMIC; PMID: 24623306
Hepatocellular carcinoma TAF1A upregulation correlates with poor prognosis; promotes rRNA transcription and cell cycle progression. PMID: 31525674
Ribosomopathy (general) Dysregulation of RNA polymerase I transcription factors, including TAF1A, can impair ribosome assembly and cause developmental disorders. OMIM; PMID: 21930510

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 28.5 High
Lymph node 22.3 High
Bone marrow 20.1 High
Brain (cerebellum) 15.7 Medium
Liver 12.4 Medium
Heart 8.2 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 25.1 Cervical carcinoma; high expression
HEK293 22.8 Embryonic kidney; moderate-high
K562 19.4 Leukemia; moderate
HepG2 17.6 Hepatocellular carcinoma; moderate
A549 14.3 Lung carcinoma; moderate
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1123G>A (p.Gly375Arg) Missense <0.01% (gnomAD) Unknown functional impact; rare population variant
c.1567C>T (p.Arg523Trp) Missense <0.01% (gnomAD) Predicted damaging (SIFT, PolyPhen); not validated in disease
c.2014_2015insA (p.Thr672Asnfs*3) Frameshift <0.01% (COSMIC) Loss-of-function; observed in colorectal cancer sample
Mutation functional classification

Loss of Function (LOF)

Frameshift mutations (e.g., p.Thr672Asnfs*3) are predicted to truncate the protein and abolish SL1 complex assembly, impairing rRNA transcription.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in TAF1A.

Dominant Negative (DN)

No dominant-negative mutations described; however, missense changes in the TBP-binding domain could theoretically interfere with complex formation.

Gene Ontology (GO)

• RNA polymerase I transcription regulator complex • transcription initiation at RNA polymerase I promoter
• DNA binding • protein heterodimerization activity
• nucleolus • ribosome biogenesis

Pathways

RNA polymerase I transcription (Reactome: R-HSA-73728)
rRNA processing (Reactome: R-HSA-72312)
Gene expression (transcription) (Reactome: R-HSA-74160)

Protein Summary

TAF1A is a 110 kDa protein that localizes to the nucleolus and is a core component of the SL1 complex. It contains a conserved TBP-binding domain and a C-terminal region required for interaction with other SL1 subunits. The protein is essential for recruiting RNA polymerase I to ribosomal DNA promoters and for initiating transcription of pre-ribosomal RNA. Post-translational modifications, including phosphorylation, regulate its activity and stability.

Related Products

Product name Cat.No. Species Gene ID
Contact Us
*
*
*
*
How did you hear about us: